Medical management of motility disorders in patients with intestinal failure: a focus on necrotizing enterocolitis, gastroschisis, and intestinal atresia
Journal of Pediatric Surgery, 08/30/2011
Dicken BJ et al. – Despite relatively poor level of evidence regarding the application of promotility and antidiarrheal medications in patients with short bowel syndrome (SBS) and intestinal failure (IF), these agents continue to be used. Herein, authors provide a review of the physiology and pathophysiology of intestinal motility/dysmotility and available strategies for the use of promotility and antidiarrheal agents in patients with IF/SBS.






